Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XIAFLEX for Urethral Stricture
NCT02948842Phase 2Completed
- Sponsor
- University of South Florida
- Start
- May 2020
- Primary completion
- Mar 2023
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of collagenase clostridium histolyticum in urethral stricture, sponsored by University of South Florida. Primary endpoint: Number of Subjects With Complication After Treatment at 84 days. Started May 2020; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
urethral stricture
Beyond the preview
Go deeper on NCT02948842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02948842.